Search research articles
Contact Us
Filters
Showing results (11-20 of 71) with videos related to
Page
of 8
Sort By:
Medicinal Chemistry (Shariqah (United Arab Emirates))
|
June 23, 2006
Synthesis, structure-activity relationships and antagonistic effects in human MCF-7 breast cancer cells of flexible estrogen receptor modulators
David G Lloyd, Helena M Smith, Timothy O'Sullivan, et al.
Mitochondrion
|
April 2, 2011
The preservation of in vivo phosphorylated and activated uncoupling protein 3 (UCP3) in isolated skeletal muscle mitochondria following administration of 3,4-methylenedioxymethamphetamine (MDMA aka ecstasy) to rats/mice
Orlagh M Kelly, Yvonne M McNamara, Lars H Manzke, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
August 2, 2016
Development of the β-lactam type molecular scaffold for selective estrogen receptor α modulator action: synthesis and cytotoxic effects in MCF-7 breast cancer cells
Miriam Carr, Andrew J S Knox, David G Lloyd, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
September 30, 2008
Beta-lactam type molecular scaffolds for antiproliferative activity: synthesis and cytotoxic effects in breast cancer cells
Mary J Meegan, Miriam Carr, Andrew J S Knox, et al.
Biochemical Pharmacology
|
June 19, 2012
The vascular targeting agent Combretastatin-A4 directly induces autophagy in adenocarcinoma-derived colon cancer cells
Lisa M Greene, Niamh M O'Boyle, Derek P Nolan, et al.
Journal of Chemical Information and Modeling
|
July 10, 2013
Structure-activity relationships in non-ligand binding pocket (non-LBP) diarylhydrazide antiandrogens
Laura Caboni, Billy Egan, Brendan Kelly, et al.
International Journal of Molecular Medicine
|
March 4, 2011
BubR1 is required for the mitotic block induced by combretastatin-A4 and a novel cis-restricted ß-lactam analogue in human cancer cells
Lisa M Greene, Miriam Carr, Niall O Keeley, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))
|
March 14, 2007
Flexible estrogen receptor modulators: synthesis, biochemistry and molecular modeling studies for 3-benzyl-4,6-diarylhex-3-ene and 3,4,6-triarylhex-3-ene derivatives
Helena M Smith, Andrew J S Knox, Daniela M Zisterer, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
November 27, 2007
Benzothiepin-derived molecular scaffolds for estrogen receptor modulators: synthesis and antagonistic effects in breast cancer cells
Mary J Meegan, Irene Barrett, Jochen Zimmermann, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))
|
June 22, 2006
Antiestrogenically active 2-benzyl-1,1-diarylbut-2-enes: synthesis, structure-activity relationships and molecular modeling study for flexible estrogen receptor antagonists
David G Lloyd, Helena M Smith, Timothy O'Sullivan, et al.
Page
of 8
Search research articles
Search
Showing results (11-20 of 71) with videos related to
Sort By:
Page
of 8
Medicinal Chemistry (Shariqah (United Arab Emirates))
|
June 23, 2006
Synthesis, structure-activity relationships and antagonistic effects in human MCF-7 breast cancer cells of flexible estrogen receptor modulators
David G Lloyd, Helena M Smith, Timothy O'Sullivan, et al.
Mitochondrion
|
April 2, 2011
The preservation of in vivo phosphorylated and activated uncoupling protein 3 (UCP3) in isolated skeletal muscle mitochondria following administration of 3,4-methylenedioxymethamphetamine (MDMA aka ecstasy) to rats/mice
Orlagh M Kelly, Yvonne M McNamara, Lars H Manzke, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
August 2, 2016
Development of the β-lactam type molecular scaffold for selective estrogen receptor α modulator action: synthesis and cytotoxic effects in MCF-7 breast cancer cells
Miriam Carr, Andrew J S Knox, David G Lloyd, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
September 30, 2008
Beta-lactam type molecular scaffolds for antiproliferative activity: synthesis and cytotoxic effects in breast cancer cells
Mary J Meegan, Miriam Carr, Andrew J S Knox, et al.
Biochemical Pharmacology
|
June 19, 2012
The vascular targeting agent Combretastatin-A4 directly induces autophagy in adenocarcinoma-derived colon cancer cells
Lisa M Greene, Niamh M O'Boyle, Derek P Nolan, et al.
Journal of Chemical Information and Modeling
|
July 10, 2013
Structure-activity relationships in non-ligand binding pocket (non-LBP) diarylhydrazide antiandrogens
Laura Caboni, Billy Egan, Brendan Kelly, et al.
International Journal of Molecular Medicine
|
March 4, 2011
BubR1 is required for the mitotic block induced by combretastatin-A4 and a novel cis-restricted ß-lactam analogue in human cancer cells
Lisa M Greene, Miriam Carr, Niall O Keeley, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))
|
March 14, 2007
Flexible estrogen receptor modulators: synthesis, biochemistry and molecular modeling studies for 3-benzyl-4,6-diarylhex-3-ene and 3,4,6-triarylhex-3-ene derivatives
Helena M Smith, Andrew J S Knox, Daniela M Zisterer, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
November 27, 2007
Benzothiepin-derived molecular scaffolds for estrogen receptor modulators: synthesis and antagonistic effects in breast cancer cells
Mary J Meegan, Irene Barrett, Jochen Zimmermann, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))
|
June 22, 2006
Antiestrogenically active 2-benzyl-1,1-diarylbut-2-enes: synthesis, structure-activity relationships and molecular modeling study for flexible estrogen receptor antagonists
David G Lloyd, Helena M Smith, Timothy O'Sullivan, et al.
Page
of 8